Penny Stocks: Stocks likely to be in focus tomorrow!
Penny Stocks: Stocks likely to be in focus tomorrow!

Penny Stocks: Stocks likely to be in focus tomorrow!

Nifty50 closed at 19,189.05, while both the mid-cap index and small-cap index performed positively in the broader markets

DSIJ Intelligence Article rating: 3.9

On Friday, the Indian equity markets ended on a positive note

Penny stock under Rs 5; Board likely to announce bonus shares, stock split and dividend!
Penny stock under Rs 5; Board likely to announce bonus shares, stock split and dividend!

Penny stock under Rs 5; Board likely to announce bonus shares, stock split and dividend!

The shares of the company saw a spurt in volume by more than 2.20 times on BSE.

DSIJ Intelligence-1 Article rating: 3.7

Earum Pharmaceuticals Limited produces and distributes pharmaceutical products. The Company offers tablets, capsules, ointments, creams, gels, powders, and syrup. Earum Pharmaceuticals markets its products globally.

2200 per cent returns: This SME stock got final approval to mitigate to capital market segment of NSE!
2200 per cent returns: This SME stock got final approval to mitigate to capital market segment of NSE!

2200 per cent returns: This SME stock got final approval to mitigate to capital market segment of NSE!

Over the past three years, the stock has witnessed substantial buying, delivering multibagger returns of over 2200 per cent

DSIJ Intelligence Article rating: 4.3

A total of 1,22,18,916 equity shares of the company will be listed and admitted to dealings on the main board of both the exchanges

Rakesh Jhunjhunwala's portfolio multibagger stock; Board announced bonus shares!
Rakesh Jhunjhunwala's portfolio multibagger stock; Board announced bonus shares!

Rakesh Jhunjhunwala's portfolio multibagger stock; Board announced bonus shares!

The stock gave multibagger returns of 113 per cent in just 1 year and over 850 per cent in 3 years.

DSIJ Intelligence-1 Article rating: 3.8

The company has a market cap of Rs 1,193 crore and reported stellar quarterly results and annual results for the year ended March 31, 2023. In FY23, net sales increased by 37.37 per cent to Rs 137.39 crore and net profit increased by 41.40 per cent to Rs 25.22 crore compared to FY22.

RSS
First15351536153715381540154215431544Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR